MedPath

A evaluation of the preference, performance and acceptability of an investigational hydrogel male condom (Geldom) compared to a commercial latex condom during vaginal intercourse.

Not Applicable
Recruiting
Conditions
nintended pregnancy
Sexually Transmitted Infections (STIs)
Unintended pregnancy
Reproductive Health and Childbirth - Contraception
Infection - Sexually transmitted infections
Registration Number
ACTRN12624000066583
Lead Sponsor
Eudaemon technologies PTY LTD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Mutually monogamous, heterosexual, current relationship greater than or equal to 3 months
Aged between 18 – 45 years (inclusive)
Sexually active, sufficient to meet protocol requirements
Agree to have penile-vaginal intercourse with frequency sufficient to meet protocol requirements and at either participants given home address in a standard environment for sexual intercourse (e.g. bedroom)
Have used 6 condoms in their lifetime, including at least 1 latex condom

Exclusion Criteria

Allergic or sensitive to the material(s) of the test or control condom;
Female partner self-reported as pregnant or desires to become pregnant while participating in the study
Male partner has had difficulty achieving or maintaining an erection, or achieving ejaculation in the last month under typical circumstances/conditions
Known allergy or sensitivity to personal lubricants, including water based or silicone lubricants
A known sexually transmitted infections including HIV/AIDS or risk of sexually transmitted infections, including HIV infection, or having a medical history of untreated and/or recurrent, serious sexually transmitted infection (e.g. Gonorrhoea, Syphilis, Chlamydia, herpes)
History of sexual anxiety and/or pain during sex;
Has any penile abnormalities (e.g. Peyronie’s disease, hypospadias, intersex, phimosis, penile cancer, micro-penis, previous penile or prostatic surgery)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath